Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BK-VAX: Adaptive Immunity Against BK Polyomavirus After Kidney Transplantation
2023-504309-35-00Phase 4Terminated
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of mycophenolate mofetil, mycophenolate sodium and sirolimus in BK polyomavirus infection and BK polyomavirus associated nephropathy (BKPyVAN) (2 arms), sponsored by Vall d'Hebron Research Institute. Primary endpoint: Change in BK virus-specific immune response and BK viral load in peripheral blood. Started Jun 2023; status: terminated.
02
Drugs
mycophenolate mofetilmycophenolate sodiumsirolimus
03
Conditions
BK polyomavirus infectionBK polyomavirus associated nephropathy (BKPyVAN)
Beyond the preview
Go deeper on 2023-504309-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504309-35-00.